Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2006 059 241.8 |
96 | EP file number | EAKZ | 16 19 1843.8 |
97 | EP publication number | EPN | 3199164 |
54 | Designation/title | TI | VERFAHREN ZUR HERSTELLUNG VON LACTOSE UNTER VERWENDUNG VON VORKLASSIFIZIERUNGSVERFAHREN SOWIE DAMIT ERZEUGTE PHARMAZEUTISCHE FORMULIERUNGEN |
51 | IPC main class | ICM (ICMV) | A61K 31/7016 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/715 (2006.01), C07H 3/00 (2006.01), C13K 5/00 (2006.01), A61K 9/00 (2006.01) |
22 | DE application date | DAT | Feb 6, 2006 |
96 | EP application date | EAT | Feb 6, 2006 |
43 | Date of first publication | OT | Aug 2, 2017 |
| Date of publication of grant | PET | Mar 18, 2020 |
71/73 | Applicant/owner | INH | DFE Pharma Technology GmbH, 47574 Goch, DE; Glaxo Group Limited, Brentford, Middlesex, GB |
72 | Inventor | IN | NEWMAN, Stephen, Ware, Hertfordshire SG12 0DP, GB; DAMHUIS, Rudolf Johanus, 7271 AB Borculo, NL |
74 | Representative | VTR | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Address for service | | HOFFMANN - EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 651755 P Feb 10, 2005
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003199164A1 Searchable text:
EP000003199164A1 Original document:
EP000003199164B1 Searchable text:
EP000003199164B1 |
43 | Date of first publication | EVT | Aug 2, 2017 |
| Date of the first transfer into DPMAregister | EREGT | Aug 3, 2017 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 29, 2025 (Show all update days)(Hide all update days)- Jan 29, 2025
- Nov 12, 2024
- Jun 27, 2024; Jan 31, 2024; Jan 27, 2023; Dec 29, 2022; Nov 25, 2022; Jul 5, 2022; Jun 9, 2022; Jan 25, 2022; Sep 23, 2021; Jan 27, 2021; Jan 7, 2021; Dec 1, 2020; Nov 12, 2020; Oct 16, 2020; Jun 4, 2020; Mar 11, 2020; Feb 27, 2020
- Historical data not available for this/these date(s)
- Aug 3, 2017
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Oct 15, 2020 |
| Issue number | HN | 48 |
| Year | PJ | 2020 |
| Publication date | VT | Nov 26, 2020 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | DFE Pharma Technology GmbH, 47574 Goch, DE |
71/73 | Previous applicant/owner | INHF | DMV-Fonterra Excipients Technology GmbH, 47574 Goch, DE, Glaxo Group Limited, Brentford, Middlesex, GB |
| Date of update of the procedure | REGT | Nov 12, 2020 |